<DOC>
	<DOCNO>NCT01332214</DOCNO>
	<brief_summary>This randomise , single-blind , placebo-controlled Phase I study investigate safety , tolerability pharmacokinetics administration single dos AZD2820 healthy male subject .</brief_summary>
	<brief_title>To Assess Safety , Tolerability Pharmacokinetics AZD2820 After Single Ascending Doses</brief_title>
	<detailed_description />
	<criteria>Provision sign date , write informed consent prior study specific procedure . Healthy male subject age ≥20 ≤45 year suitable vein cannulation repeat venepuncture . Male subject willing use barrier contraception ie , condom , day dose 3 month dose investigational product . Have body mass index ( BMI ) between≥ 18 ≤30 kg/m2 weigh least 50 kg 100 kg . Provision sign , write date informed consent genetic research . If subject decline participate genetic component study , penalty loss benefit subject . The subject exclude aspect study describe Clinical Study Protocol , long consent . History clinically significant disease disorder , opinion investigator , may either put subject risk participation study , influence result subject 's ability participate study History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug A history erectile dysfunction anatomic abnormality penis ( eg , cavernosal fibrosis , Peyronie 's disease , plaque ) interfere normal erectile function Predisposition history priapism ( eg , sickle cell anemia trait ) . Any clinically significant illness , medical/surgical procedure trauma within 4 week first administration investigational product</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>healthy male volunteer</keyword>
	<keyword>dose escalation</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>Single Ascending Dose</keyword>
	<keyword>AZD2820 Cmax</keyword>
	<keyword>tmax</keyword>
	<keyword>t1/2λz</keyword>
</DOC>